Dario A. Paggiarino - Net Worth and Insider Trading
Dario A. Paggiarino Net Worth
The estimated net worth of Dario A. Paggiarino is at least $720,609 dollars as of 2024-05-04. Dario A. Paggiarino is the Chief Medical Officer of EyePoint Pharmaceuticals Inc and owns about 36,505 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $720,609. Details can be seen in Dario A. Paggiarino's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dario A. Paggiarino has not made any transactions after 2024-01-26 and currently still holds the listed stock(s).
Transaction Summary of Dario A. Paggiarino
Dario A. Paggiarino Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dario A. Paggiarino owns 2 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , and Apollo Endosurgery Inc (APEN) .
Click here to see the complete history of Dario A. Paggiarino’s form 4 insider trades.
Insider Ownership Summary of Dario A. Paggiarino
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2024-01-26 | Chief Medical Officer |
| APEN | Apollo Endosurgery Inc | 2013-04-15 | Sr VP & Chief Dev Officer |
Dario A. Paggiarino Latest Holdings Summary
Dario A. Paggiarino currently owns a total of 1 stock. Dario A. Paggiarino owns 36,505 shares of EyePoint Pharmaceuticals Inc (EYPT) as of January 26, 2024, with a value of $720,609.
Latest Holdings of Dario A. Paggiarino
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2024-01-26 | 36,505 | 19.74 | 720,609 |
Holding Weightings of Dario A. Paggiarino
Dario A. Paggiarino Form 4 Trading Tracker
According to the SEC Form 4 filings, Dario A. Paggiarino has made a total of 6 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the sale of 49,325 shares on January 26, 2024, which brought Dario A. Paggiarino around $1 Million.
Insider Trading History of Dario A. Paggiarino
- 1
Dario A. Paggiarino Trading Performance
Dario A. Paggiarino Ownership Network
Dario A. Paggiarino Owned Company Details
What does EyePoint Pharmaceuticals Inc do?
Who are the key executives at EyePoint Pharmaceuticals Inc?
Dario A. Paggiarino is the Chief Medical Officer of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include SVP & Chief Commercial Officer David Scott Jones , director & President and CEO Nancy Lurker , and Chief Corp Dev.&Strat. Officer Michael Craig Pine .
EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary
Over the past 18 months, Dario A. Paggiarino made 6 insider transaction in EyePoint Pharmaceuticals Inc (EYPT) with a net sale of 121,307. Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net purchase of 3,944,057 shares made by Cormorant Asset Management, Lp , and a net sale of 73,192 shares made by David Scott Jones .
In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 581,765 shares, with a net purchase of 581,765 shares. During the past 18 months, 4,194,936 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 3,944,057 shares were bought by its insiders, resulting in a net sale of 250,879 shares.
EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
EyePoint Pharmaceuticals Inc Insider Transactions
Dario A. Paggiarino Mailing Address
Above is the net worth, insider trading, and ownership report for Dario A. Paggiarino. You might contact Dario A. Paggiarino via mailing address: 4025 Sorrento Valley Blvd., San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
